Rhenman & Partners wins four prestigious awards at the Nordic Hedge Awards: Best Nordic Hedge Fund Overall 2017, Best Nordic Equity Hedge Fund 2017, and Best Performance Awards for 1 and 5 Years respectively.

The sector fund Rhenman Healthcare Equity L/S was named as a four-time winner at this
year’s Nordic Hedge Awards; best hedge fund of all Nordic hedge funds (of which there are
154), best Nordic equity hedge fund, and best-performing Nordic hedge fund for one and five
years respectively.
The awards were made in the categories “Best Nordic Hedge Fund Overall 2017″, “Best
Nordic Equity Hedge Fund 2017”, “Performance Award for 12 Months” and “Performance
Award for 60 Months”.
“We are tremendously pleased over these awards. The Nordic Hedge Award is the most
prestigious Nordic award for hedge funds and a total of 154 funds were evaluated in 2017.
To put it simply, this is the Nordic championship and for an equity hedge fund to win in four of
five possible categories is a testament to our unique investment process which leads the
way, even internationally,” says Carl Grevelius, co-founder and head of investor relations.
“Our success depends largely on the fund managers’ many years of close collaboration with
the medical experts in our Scientific Advisory Board. Equally important is our investment
team’s single focus on the healthcare sector which includes
pharmaceuticals, biotechnology, medical technology and service. This sectoral focus
probably gives us a knowledge advantage compared to those investors who monitor
and invest in a number of sectors.”
Rhenman Healthcare Equity L/S has an unprecedented performance history since its
inception in June 2009. The main fund class, the IC1 (EUR), has increased 426 percent in
total, which corresponds to an average annual return of 21 percent. In 2017, the fund
delivered a return of 35 percent. At present, assets under management in the fund amount to
approximately 600 million EUR. In accordance with the fund’s prospectus, the fund will close
for new investments when its assets reach 1 billion EUR.
For further information, please contact:
Carl Grevelius, Founding Partner / Head of Investor Relations
Phone: +46 8 459 88 83
Email: carl@rhepa.com
www.rhepa.com

About Rhenman & Partners
Rhenman & Partners Asset Management, founded in 2008, is a Stockholm-based asset
manager focusing on two niche funds: Rhenman Healthcare Equity L/S, launched in June
2009, and Rhenman Global Opportunities L/S, launched in August 2016. Assets under
management amount to approximately 600 MEUR. The management teams of the two funds
are supported in their respective investment processes by renowned advisors consisting of,
among others, eminent professors and experts with many years of market experience and
extensive expert networks around the world.